Taxol News and Research

RSS
Taxol is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Taxol is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called paclitaxel.
NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

European Patent Office announces intention to grant patent for Phyton Biotech's methods of producing taxanes

Kevetrin reduces tumor volume by 72%: Cellceutix

Kevetrin reduces tumor volume by 72%: Cellceutix

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

$1.2 million grant to study centrosomes and cilia and their connections to human disease

$1.2 million grant to study centrosomes and cilia and their connections to human disease

Drug carrier that cuts off blood supply to tumors

Drug carrier that cuts off blood supply to tumors

Six research project grants aimed at improving human health awarded

Six research project grants aimed at improving human health awarded

Update on Prolindac clinical development plan provided by Access Pharmaceuticals

Update on Prolindac clinical development plan provided by Access Pharmaceuticals

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

OSI Pharmaceuticals initiates two clinical trials with OSI-906 oral insulin-like growth factor-1 receptor inhibitor

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Discovery of compounds that selectively kills cancer stem cells

Discovery of compounds that selectively kills cancer stem cells

Dramatic drop in deaths from most common cancers

Dramatic drop in deaths from most common cancers

Taxol-carrying nanoparticles

Taxol-carrying nanoparticles

New research sheds light on ways to improve treatment for aggressive breast cancer

New research sheds light on ways to improve treatment for aggressive breast cancer

Researchers target telomeres to attack tumors

Researchers target telomeres to attack tumors

Brain metastases hijack neuron-supporting cells to resist chemotherapy

Brain metastases hijack neuron-supporting cells to resist chemotherapy

FDA grants Oasmia's Paclical orphan drug designation for ovarian cancer in U.S.

FDA grants Oasmia's Paclical orphan drug designation for ovarian cancer in U.S.

Santaris Pharma releases positive data on LNA-based survivin inhibitor

Santaris Pharma releases positive data on LNA-based survivin inhibitor

neuMirRx issued U.S. patent for "methods for enhancing solubility of compounds

neuMirRx issued U.S. patent for "methods for enhancing solubility of compounds

Nanotubes detect tumors and deliver high-potency punch

Nanotubes detect tumors and deliver high-potency punch